XHQHX H & Q Healthcare Investors

Tekla Healthcare Investors Announce Renewal of Share Repurchase Program

Tekla Healthcare Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2018. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2019. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund’s shares and the net asset value per share. The share repurchase program is intended to increase the Fund’s net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.

The amount and timing of repurchases will be at the discretion of Tekla Capital Management LLC, the investment adviser to the Fund. There is no assurance that the Fund will purchase shares at any specific discount levels or in any specific amounts or on any specific date. The Fund’s repurchase activity will be disclosed in its shareholder report for the relevant fiscal period. There is no assurance that the market price of the Fund’s shares, either absolute or relative to net asset value, will increase as a result of any share repurchases. The Board will monitor the effect of the share repurchase program on the Fund’s market prices and net asset value per share, expense ratio and investment strategy over time.

Tekla Healthcare Investors (NYSE: HQH) is a closed-end fund that invests in companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as investment adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.

For additional information, please consult www.teklacap.com or call (877) 855-3434.

EN
22/03/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on H & Q Healthcare Investors

 PRESS RELEASE

Tekla Healthcare Investors Paid Distribution

BOSTON--(BUSINESS WIRE)-- On March 29, 2018, Tekla Healthcare Investors paid a distribution of $0.48 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, long-term capital gains and return of capital or other source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net reali...

 PRESS RELEASE

Tekla Healthcare Investors Announce Renewal of Share Repurchase Progra...

BOSTON--(BUSINESS WIRE)-- Tekla Healthcare Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2018. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2019. The Board authorized the share repurchase program as a r...

 PRESS RELEASE

Tekla Healthcare Investors Declares Stock Distribution

BOSTON--(BUSINESS WIRE)-- On February 16, 2018, Tekla Healthcare Investors declared a stock distribution of $0.48 per share. The record date for the stock distribution is February 28, 2018 and the payable date is March 29, 2018. The Fund will trade ex-distribution on February 27, 2018. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23, 2...

A director bought 1,100 shares at 24.186USD and

A director at Tekla Healthcare Investors bought 1,100 shares at 24.186USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Tekla Healthcare Investors Paid Distribution

BOSTON--(BUSINESS WIRE)-- On December 29, 2017, Tekla Healthcare Investors paid a distribution of $0.52 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains and return of capital or other source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch